Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
American Academy of Neurology 2012 Annual Meeting
Cuprizone neurotoxicity in the rat: morphologic observations.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
The quality of reports of randomized trials in multiple sclerosis: a review.
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Neuroscience 2014
Glia in Health & Disease
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Estrogen and testosterone therapies in multiple sclerosis.
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
Neuroprotection in a novel mouse model of multiple sclerosis.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
Request for Applications for Collaborative Network Awards from the Progressive MS Alliance
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
Keystone Symposium: Dendritic Cells and Macrophages Reunited

Pages